Insulin Lispro
| Drug Category | Drug | IHD Dosing | Administration Timing Around HD Session |
|---|---|---|---|
| Diabetes Medications | Insulin Lispro | Administer 25-50% of normal dose and titrate | Administer Anytime During HD |
Molecular Weight (Da) | Excreted Unchanged (%) | Normal Half-Life (Hours) | ESRD Half-Life (Hours) | Plasma Protein Binding (%) | Volume of Distribution (L/kg) | Dialytic Plasma Clearance (ml/min) | % Dialyzed |
|---|---|---|---|---|---|---|---|
| 5814 | N/A | 1 | Prolonged | N/A | 0.26-0.36 | N/A | N/A |
References:
- DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugbank.ca/drugs/DB00046
- Iglesias P, Díez J. Insulin therapy in renal disease. Diabetes, obesity & metabolism. 2008;10(10):811-23.